189 related articles for article (PubMed ID: 6072765)
1. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
[No Abstract] [Full Text] [Related]
2. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
Mori T; Kriss JP
J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
[No Abstract] [Full Text] [Related]
3. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
Furth ED; Dentinger M
Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
[No Abstract] [Full Text] [Related]
4. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
McKenzie JM; Zakarija M
J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
6. Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum.
Miyai K; Werner SC
J Clin Endocrinol Metab; 1966 May; 26(5):504-12. PubMed ID: 5952570
[No Abstract] [Full Text] [Related]
7. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
[No Abstract] [Full Text] [Related]
8. Studies on a receptor assay for an antibody to human thyroid plasma membrane.
Ochi Y; Hosoda S; Hachiya T; Yoshimura M; Miyazaki T; Kajita Y
Acta Endocrinol (Copenh); 1979 May; 91(1):89-98. PubMed ID: 582221
[No Abstract] [Full Text] [Related]
9. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
10. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
Selenkow HA; Wyman P; Allweiss P
Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
[TBL] [Abstract][Full Text] [Related]
11. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
12. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
Yabu Y; Amino N; Mori H; Miyai K; Tanizawa O; Takai SI; Kumahara Y; Matsuzuka F; Kuma K
J Clin Endocrinol Metab; 1980 Dec; 51(6):1454-8. PubMed ID: 6108332
[TBL] [Abstract][Full Text] [Related]
13. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
Balázs C
Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
[TBL] [Abstract][Full Text] [Related]
14. [Human thyroid stimulator (HTS) in thyroid diseases].
Hu ZY
Zhonghua Nei Ke Za Zhi; 1984 Aug; 23(8):480-3, 525. PubMed ID: 6548953
[No Abstract] [Full Text] [Related]
15. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
Hopf U; Fiek T; Grün R; Zuschneid W
J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
[TBL] [Abstract][Full Text] [Related]
16. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
17. [TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease].
Shishiba Y
Nihon Rinsho; 1983; 41(4):801-7. PubMed ID: 6310180
[No Abstract] [Full Text] [Related]
18. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
19. The significance of antithyroglobulin and antithyroidal microsomal antibodies in patients with hyperthyroidism due to Graves' disease treated with antithyroidal drugs.
Takaichi Y; Tamai H; Honda K; Nagai K; Kuma K; Nakagawa T
J Clin Endocrinol Metab; 1989 Jun; 68(6):1097-100. PubMed ID: 2470772
[TBL] [Abstract][Full Text] [Related]
20. [Incidence of antithyroglobulin and antimicrosomal antibodies in thyroid pathology].
Vallée G; Izembart M; Thonnet M
Ann Biol Clin (Paris); 1982; 40(6):651-6. PubMed ID: 6897699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
